Promoter characterization and genomic organization of the human breast cancer resistance protein (ATP-binding cassette transporter G2) gene

被引:185
作者
Bailey-Dell, KJ
Hassel, B
Doyle, LA
Ross, DD
机构
[1] Univ Maryland, Dept Pathol, Sch Med, Baltimore, MD 21201 USA
[2] Univ Maryland, Greenebaum Canc Ctr, Program Expt Therapeut, Baltimore, MD 21201 USA
[3] Univ Maryland, Dept Microbiol, Sch Med, Baltimore, MD 21201 USA
[4] Univ Maryland, Dept Med, Sch Med, Baltimore, MD 21201 USA
[5] Baltimore Vet Med Ctr, Baltimore, MD 21201 USA
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION | 2001年 / 1520卷 / 03期
关键词
promoter region; genomic organization; breast cancer resistance protein; ATP-binding cassette transporter G2 choriocarcinoma; SP1;
D O I
10.1016/S0167-4781(01)00270-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The breast cancer resistance protein (BCRP) gene, formally known as ATP-binding cassette transporter G2 (ABCG2) gene, encodes an ABC half transporter that causes resistance to certain cancer chemotherapeutic drugs when transfected and expressed in drug sensitive cancer cells. Here we report the organization of the BCRP gene, and the initial characterization of the BCRP promoter. We identified the genomic sequence of BCRP and its promoter by screening a human genomic lambda phage library, as well as a BAC library, and by searching the human genome database. The BCRP gene spans over 66 kb and consists of 16 exons and 15 introns. The exons range in size from 60 to 532 bp. The translational start site is found in the second exon. The first exon contains the majority of the 5' UTR. Promoter activity was characterized by a luciferase reporter assay using transient transfection of the human breast cancer cell line MCF7, and the human choriocarcinoma cell lines JAR, BeWo and JEG-3, which we find to have high endogenous expression of BCRP. The BCRP gene is transcribed by a TATA-less promoter with several putative Sp1 sites. which are downstream from a putative CpG island. The sequence 312 bp directly upstream from the BCRP transcriptional start site conferred basal promoter activity. The 5' region upstream of the basal promoter is characterized by both positive and negative regulatory domains. (C) 2001 Published by Elsevier Science B.V.
引用
收藏
页码:234 / 241
页数:8
相关论文
共 28 条
  • [1] Allikmets R, 1998, CANCER RES, V58, P5337
  • [2] BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025
  • [3] A multidrug resistance transporter from human MCF-7 breast cancer cells
    Doyle, LA
    Yang, WD
    Abruzzo, LV
    Krogmann, T
    Gao, YM
    Rishi, AK
    Ross, DD
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15665 - 15670
  • [4] MECHANISMS OF MRP OVER-EXPRESSION IN 4 HUMAN LUNG-CANCER CELL-LINES AND ANALYSIS OF THE MRP AMPLICON
    EIJDEMS, EWHM
    DEHAAS, M
    COCOMARTIN, JM
    OTTENHEIM, CPE
    ZAMAN, GJR
    DAUWERSE, HG
    BREUNING, MH
    TWENTYMAN, PR
    BORST, P
    BAAS, F
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 60 (05) : 676 - 684
  • [5] High rate of MDR-1 and heterogeneous pattern of MRP expression without gene amplification in endometrial cancer
    Esteller, M
    MartinezPalones, JM
    Garcia, A
    Xercavins, J
    Reventos, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (06) : 798 - 803
  • [6] EWART GD, 1994, J BIOL CHEM, V269, P10370
  • [7] A novel method to develop highly specific models for regulatory units detects a new LTR in GenBank which contains a functional promoter
    Frech, K
    DanescuMayer, J
    Werner, T
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 1997, 270 (05) : 674 - 687
  • [8] HOLMES JA, 1992, LEUKEMIA, V6, P484
  • [9] Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan
    Jonker, JW
    Smit, JW
    Brinkhuis, RF
    Maliepaard, M
    Beijnen, JH
    Schellens, JHM
    Schinkel, AH
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (20): : 1651 - 1656
  • [10] Functional promoter modules can be defected by formal models independent of overall nucleoside sequence similarity
    Klingenhoff, A
    Frech, K
    Quandt, K
    Werner, T
    [J]. BIOINFORMATICS, 1999, 15 (03) : 180 - 186